Home » Topics » Gastrointestinal, BioWorld Science

Gastrointestinal, BioWorld Science
RSS

PTCA shows therapeutic potential for NASH

May 27, 2005

HCV-796 moves into phase Ib trial in hepatitis C patients

May 26, 2005

Preclinical data on TZP-101, a novel GHS-R1a agonist, for the treatment of gastric motility disorder

May 26, 2005

STA-5326 shows potential for Crohn's disease

May 24, 2005

Fontolizumab reduces Crohn's disease activity in an open-label study

May 24, 2005

Chiron and Enanta agree to develop and commercialize HCV protease inhibitors

May 24, 2005

Recent Japan Tobacco patent describes new antihepatitis C agents

May 23, 2005

Atilmotin speeds gastrointestinal transit in humans

May 23, 2005

Baseline lipid profile may help predict treatment outcome in hepatitis C patients

May 23, 2005

Ghrelin analogue RC-1139 exerts gastrokinetic effects in rats

May 20, 2005

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 31, 2026.
New schizophrenia targets challenge trial design
BioWorld
The search for better schizophrenia therapies is moving beyond dopamine toward a growing number of experimental targets. According to researchers, the repeated...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 28, 2026
AIDS 2026: New targets for metabolic dysfunction despite ART
BioWorld
Although antiretroviral therapy (ART) can suppress HIV to undetectable levels, a growing body of evidence suggests that the virus leaves a lasting biological...
Taiwan biotech looks outward in next phase of growth
BioWorld
Taiwan’s biotechnology sector was built around domestic health needs, including vaccines and drug manufacturing, but it is increasingly looking outward – to...